[HTML][HTML] SETD2: from chromatin modifier to multipronged regulator of the genome and beyond

TM Molenaar, F van Leeuwen - Cellular and Molecular Life Sciences, 2022 - Springer
Histone modifying enzymes play critical roles in many key cellular processes and are
appealing proteins for targeting by small molecules in disease. However, while the functions …

Molecular mechanisms in governing genomic stability and tumor suppression by the SETD2 H3K36 methyltransferase

UTF Lam, ES Chen - The International Journal of Biochemistry & Cell …, 2022 - Elsevier
Epigenetic dysregulation is an important contributor to carcinogenesis. This is not surprising,
as chromatin—genomic DNA organized around structural histone scaffolding—serves as the …

[HTML][HTML] N6-Methyladenosine methylation regulator RBM15 is a potential prognostic biomarker and promotes cell proliferation in pancreatic adenocarcinoma

Z Zhao, Q Ju, J Ji, Y Li, Y Zhao - Frontiers in Molecular Biosciences, 2022 - frontiersin.org
RNA binding motif protein 15 (RBM15) is a key regulatory factor involved in N6-
methyladenosine (m6A) methylation. It has been reported that RBM15 plays an important …

Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101 …

J Liu, Y Shi, Y Zhang - EPMA Journal, 2023 - Springer
Background Clear cell renal cell carcinoma (ccRCC) is a prevalent urological malignancy
associated with a high mortality rate. The lack of a reliable prognostic biomarker undermines …

Gene expression profiling identifies two chordoma subtypes associated with distinct molecular mechanisms and clinical outcomes

J Bai, J Shi, Y Zhang, C Li, Y Xiong, H Koka… - Clinical Cancer …, 2023 - AACR
Purpose: Chordoma is a rare bone tumor with a high recurrence rate and limited treatment
options. The aim of this study was to identify molecular subtypes of chordoma that may …

[HTML][HTML] A pan-cancer bioinformatic analysis of RAD51 regarding the values for diagnosis, prognosis, and therapeutic prediction

H Liu, J Weng - Frontiers in oncology, 2022 - frontiersin.org
Background RAD51, a critical protein for DNA repairment, has been found to associate with
multiple cancer types, but, so far, a systematic pan-cancer analysis of RAD51 has not been …

[HTML][HTML] Multi-omics analysis of MCM2 as a promising biomarker in pan-cancer

J Yuan, H Lan, D Huang, X Guo, C Liu, S Liu… - Frontiers in cell and …, 2022 - frontiersin.org
Minichromosome maintenance 2 (MCM2) is a member of the minichromosomal
maintenance family of proteins that mainly regulates DNA replication and the cell cycle and …

Alternative complement pathway signature determines immunosuppression and resistance to immunotherapy plus tyrosine kinase inhibitor combinations in renal cell …

J Wang, S Zhang, Y Wang, Y Zhu, X Xu… - … Oncology: Seminars and …, 2023 - Elsevier
Background Latest guidelines recommended immunotherapy (IO) plus tyrosine kinase
inhibitor (TKI) combination as standard first-line therapy in renal cell carcinoma (RCC), with …

[HTML][HTML] Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor types

FS Kong, CY Ren, R Jia, Y Zhou, JH Chen, Y Ma - BMC medical genomics, 2023 - Springer
Abstract Background Solute Carrier Family 31 Member 1 (SLC31A1) has recently been
identified as a cuproptosis-regulatory gene. Recent studies have indicated that SLC31A1 …

[HTML][HTML] SETD2-H3K36ME3: an important bridge between the environment and tumors

J He, T Xu, F Zhao, J Guo, Q Hu - Frontiers in Genetics, 2023 - frontiersin.org
Epigenetic regulation plays an important role in the occurrence, development and treatment
of tumors. The histone methyltransferase SET-domain-containing 2 (SETD2) plays a key role …